His first academic employment was at the University of Colorado studying the metabolism of premature babies. In 1952 he moved toWashington University in St. Louis, working first in the department of radiology, learning isotope methodology, and then in the department of zoology. Working withRita Levi-Montalcini, he isolated nerve growth factor. He later isolated a protein that could accelerate incisor eruption and eyelid opening in newborn mice,[7] which was renamed epidermal growth factor.[8] He continued research on cellular growth factors after joining the faculty ofVanderbilt University School of Medicine in 1959.[6]
Cohen in 2007
In 1999, Cohen retired from Vanderbilt University.[9] He died in February 2020 at the age of 97.[10][11]
^Cohen, Stanley (1993)."Epidermal Growth Factor"(PDF). In Tore Frängsmyr; Jan Lindsten (eds.).Nobel Lectures, Physiology or Medicine 1981–1990. Singapore: World Scientific Publishing Co.ISBN978-981-02-0793-9.Archived(PDF) from the original on 2010-12-15. Cohen's Nobel Lecture.
^Weltman, J. K. (1987). "The 1986 Nobel Prize for Physiology or Medicine awarded for discovery of growth factors: Rita Levi-Montalcini, M.D., and Stanley Cohen, Ph.D".New England and Regional Allergy Proceedings.8 (1):47–48.doi:10.2500/108854187779045385.PMID3302667.
